That’s a Wrap on the 2018 NCRA Convention & Expo

The annual National Court Reporters Association Convention & Expo has wrapped up, and by all accounts, it was a tremendous success. Held in the heart of New Orleans, participants had the opportunity to view the latest and greatest products, take part in valuable learning sessions, and even play games. With so much to see and do, the 2018 NCRA Convention & Expo did not disappoint!

As always, Stenograph was an active contributor to this year’s convention. With the largest booth of any company, we had our newest product offerings on display for convention goers to test out. Stenograph Product Manager Alex Cotteleer remarked, “The energy was great at the show and everyone was genuinely excited about the new offerings.”

New Products and Offerings on Display

Stenograph is constantly innovating products and technology to enhance stenographer performance, and NCRA was the perfect venue to allow the court reporting community the opportunity to experience our latest game-changing offerings and features, including:

  • New Luminex colors – Platinum, Aqua, and Blue Carbon Fiber
  • CasViewNet’s new chat feature
  • Stenograph Askbot community help forum
  • Luminex Wi-Fi capabilities
  • Universal Bar Tension Toggle

Our enormous booth was quite a sight to see, too. Rolling out new products, demonstrating new features, and raising the energy level of the entire building, the Stenograph booth was all the buzz.

Stenograph Training Seminar

Beyond our dynamic booth exhibit and demonstrations, Stenograph also conducted a training seminar at NCRA 2018. During the session, participants were able to learn more about our company and all the product features available to them.

In New Orleans, they say, “Let the good times roll,” and the convention goers took that message to heart. “It was just an overall smooth and positive show,” says Cotteleer.

With such incredible displays, seminars, and activities, the four-day convention in the Big Easy seemed to fly by. Everyone here at Stenograph is thankful to the NCRA and all the expo participants for making this year’s convention one to remember!

Learn more about the new Stenograph products and offerings today!

Read more at stenograph.com

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More